"AI's Impact on Health Care Decision-Making and Legislation"

The use of unregulated artificial intelligence tools in healthcare, such as predictive software and virtual assistants, has outpaced government regulation, posing challenges for agencies like the FDA. The FDA lacks the resources and authority to effectively oversee the constantly evolving AI technology, leading to calls for public-private assurance labs to validate and monitor AI in healthcare. Industry backlash and confusion over the scope of FDA authority further complicate the regulatory landscape, while concerns persist about the effectiveness of current oversight and the need for AI systems to demonstrate improved patient outcomes.